Serum Level of Complement C1q is Associated with Contrast-Associated Acute Kidney Injury in Patients Undergoing Emergency Percutaneous Coronary Intervention

References

• Rundback JH, Nahl D, Yoo V. Contrast-induced nephropathy. J Vasc Surg. 2011;54:575–579. doi:10.1016/j.jvs.2011.04.047
   PubMed Web of Science ®Google Scholar
• Zhang F, Lu Z, Wang F. Advances in the pathogenesis and prevention of contrast-induced nephropathy. Life Sci. 2020;259:118379. doi:10.1016/j.lfs.2020.118379
   PubMed Web of Science ®Google Scholar
• Mehran R, Dangas GD, Weisbord SD. Contrast-associated acute kidney injury. N Engl J Med. 2019;380:2146–2155. doi:10.1056/NEJMra1805256
   PubMed Web of Science ®Google Scholar
• Wi J, Ko YG, Kim JS, et al. Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart. 2011;97:1753–1757. doi:10.1136/hrt.2010.218677
   PubMed Web of Science ®Google Scholar
• Efe SC, Karagöz A, Doğan C, et al. Prognostic significance of malnutrition scores in elderly patients for the prediction of contrast-induced acute kidney injury. Int J Clin Pract. 2021;75:e14274. doi:10.1111/ijcp.14274
   PubMed Web of Science ®Google Scholar
• Putzu A, Boscolo Berto M, Belletti A, et al. Prevention of contrast-induced acute kidney injury by furosemide with matched hydration in patients undergoing interventional procedures: a systematic review and meta-analysis of randomized trials. JACC Cardiovasc Interv. 2017;10:355–363. doi:10.1016/j.jcin.2016.11.006
   PubMed Web of Science ®Google Scholar
• Ma H, Sandor DG, Beck LH Jr. The role of complement in membranous nephropathy. Semin Nephrol. 2013;33:531–542. doi:10.1016/j.semnephrol.2013.08.004
   PubMed Web of Science ®Google Scholar
• Thurman JM. Complement and the kidney: an overview. Adv Chronic Kidney Dis. 2020;27:86–94. doi:10.1053/j.ackd.2019.10.003
   PubMed Web of Science ®Google Scholar
• Willows J, Brown M, Sheerin NS. The role of complement in kidney disease. Clin Med (Lond). 2020;20:156–160. doi:10.7861/clinmed.2019-0452
   PubMed Web of Science ®Google Scholar
• Teh BK, Yeo JG, Chern LM, et al. C1q regulation of dendritic cell development from monocytes with distinct cytokine production and T cell stimulation. Mol Immunol. 2011;48:1128–1138. doi:10.1016/j.molimm.2011.02.006
   PubMed Web of Science ®Google Scholar
• Skoglund C, Wetterö J, Bengtsson T. C1q regulates collagen-dependent production of reactive oxygen species, aggregation and levels of soluble P-selectin in whole blood. Immunol Lett. 2012;142:28–33. doi:10.1016/j.imlet.2011.11.003
   PubMed Web of Science ®Google Scholar
• Tenner AJ, Cooper NR. Stimulation of a human polymorphonuclear leukocyte oxidative response by the C1q subunit of the first complement component. J Immunol. 1982;128:2547–2552.
   PubMed Web of Science ®Google Scholar
• Yin W, Ghebrehiwet B, Weksler B, et al. Classical pathway complement activation on human endothelial cells. Mol Immunol. 2007;44:2228–2234. doi:10.1016/j.molimm.2006.11.012
   PubMedGoogle Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate [published correction appears in Ann Intern Med. 2011 Sep 20;155(6):408]. Ann Intern Med. 2009;150:604–612. doi:10.7326/0003-4819-150-9-200905050-00006
   PubMed Web of Science ®Google Scholar
• Stacul F, van der Molen AJ, Reimer P, et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol. 2011;21:2527–2541. doi:10.1007/s00330-017-5247-4
   PubMed Web of Science ®Google Scholar
• Toprak O, Cirit M. Risk factors for contrast-induced nephropathy. Kidney Blood Press Res. 2006;29(2):84–93. doi:10.1159/000093381
   PubMed Web of Science ®Google Scholar
• Okoye O, Ojogwu L, Unuigbe E, Oviasu E. Frequency and risk factors of contrast-induced nephropathy after contrast procedures in a Nigerian tertiary centre. West Afr J Med. 2013;32(1):19–25.
   PubMedGoogle Scholar
• Yuan Y, Qiu H, Hu X, et al. Predictive value of inflammatory factors on contrast-induced acute kidney injury in patients who underwent an emergency percutaneous coronary intervention. Clin Cardiol. 2017;40(9):719–725. doi:10.1002/clc.22722
   PubMed Web of Science ®Google Scholar
• Dalmasso AP. Complement in the pathophysiology and diagnosis of human diseases. Crit Rev Clin Lab Sci. 1986;24:123–183. doi:10.3109/10408368609110272
   PubMed Web of Science ®Google Scholar
• Tedesco F, Pausa M, Nardon E, et al. The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity. J Exp Med. 1997;185:1619–1627. doi:10.1084/jem.185.9.1619
   PubMed Web of Science ®Google Scholar
• Eriksson O, Mohlin C, Nilsson B, et al. The human platelet as an innate immune cell: interactions between activated platelets and Eriksson O, Mohlin C, Nilsson B, Ekdahl KN. The complement system. Front Immunol. 2019;10:1590. doi:10.3389/fimmu.2019.01590
   PubMed Web of Science ®Google Scholar
• Kilgore KS, Ward PA, Warren JS. Neutrophil adhesion to human endothelial cells is induced by the membrane attack complex: the roles of P-selectin and platelet activating factor. Inflammation. 1998;22:583–598. doi:10.1023/a:1022362413939
   PubMed Web of Science ®Google Scholar
• Sun ZJ, Li XQ, Chang DY, et al. Complement deposition on renal histopathology of patients with diabetic nephropathy. Diabetes Metab. 2019;45:363–368. doi:10.1016/j.diabet.2018.08.011
   PubMed Web of Science ®Google Scholar
• Imai H, Yasuda T, Satoh K, et al. Pan-nephritis (glomerulonephritis, arteriolitis, and tubulointerstitial nephritis) associated with predominant mesangial C1q deposition and hypocomplementemia: a variant type of C1q nephropathy? Am J Kidney Dis. 1996;27:583–587. doi:10.1016/s0272-6386(96)90171-7
   PubMed Web of Science ®Google Scholar
• Rossen RD, Reisberg MA, Singer DB, et al. Soluble immune complexes in sera of patients with nephritis. Kidney Int. 1976;10:256–263. doi:10.1038/ki.1976.105
   PubMed Web of Science ®Google Scholar
• Wong PC, Li Z, Guo J, et al. Pathophysiology of contrast-induced nephropathy. Int J Cardiol. 2012;158:186–192. doi:10.1016/j.ijcard.2011.06.115
   PubMed Web of Science ®Google Scholar
• Castellano G, Melchiorre R, Loverre A, et al. Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage. Am J Pathol. 2010;176:1648–1659. doi:10.2353/ajpath.2010.090276
   PubMed Web of Science ®Google Scholar
• Li K, Sacks SH, Zhou W. The relative importance of local and systemic complement production in ischaemia, transplantation and other pathologies. Mol Immunol. 2007;44:3866–3874. doi:10.1016/j.molimm.2007.06.006
   PubMed Web of Science ®Google Scholar
• Heyman SN, Rosen S, Khamaisi M, et al. Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy. Invest Radiol. 2010;45:188–195. doi:10.1097/RLI.0b013e3181d2eed8
   PubMed Web of Science ®Google Scholar
• Ghebrehiwet B, CebadaMora C, Tantral L, et al. gC1qR/p33 serves as a molecular bridge between the complement and contact activation systems and is an important catalyst in inflammation. Adv Exp Med Biol. 2006;586:95–105. doi:10.1007/0-387-34134-X_7
   PubMed Web of Science ®Google Scholar